Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Labinson
Paul
P
University of Connecticut School of Medicine, Division of Endocrinology and Metabolism, Farmington, USA.
Taxel
Pamela
P
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000627:therapeutic use; D012968:Etidronic Acid / Q000009:adverse effects*; D005260:Female; D005598:Fractures, Spontaneous / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D010018:Osteomalacia / Q000139:chemically induced* / Q000517:prevention & control
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D012968:Etidronic Acid